DOI:
10.1055/s-00050348
Indian Journal of Medical and Paediatric Oncology
LinksClose Window
References
Tan AR, Yang X, Berman A, Zhai S, Sparreboom A, Parr AL. et al.
Phase I trial of the cyclin-dependent kinase inhibitor flavopiridol in combination with docetaxel in patients with metastatic breast cancer.
Clin Cancer Res 2004;
10: 5038-47
We do not assume any responsibility for the contents of the web pages of other providers.